ArticleCancer research communications2026

Identification and Validation of the ESR1 Y537S Mutant-Enriched Enhancer and Its Downstream Target IGFBP3.

Yonatan Amzaleg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.